159 related articles for article (PubMed ID: 29960201)
1. A study of treatments and outcomes in elderly women with cervical cancer.
Shimamoto K; Saito T; Kitade S; Tomita Y; Nagayama R; Yamaguchi S; Ariyoshi K; Okadome M
Eur J Obstet Gynecol Reprod Biol; 2018 Sep; 228():174-179. PubMed ID: 29960201
[TBL] [Abstract][Full Text] [Related]
2. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
[TBL] [Abstract][Full Text] [Related]
3. Outcome and toxicity of radical radiotherapy or concurrent Chemoradiotherapy for elderly cervical cancer women.
Wang W; Hou X; Yan J; Shen J; Lian X; Sun S; Liu Z; Meng Q; Wang D; Zhao M; Qiu J; Hu K; Zhang F
BMC Cancer; 2017 Aug; 17(1):510. PubMed ID: 28764676
[TBL] [Abstract][Full Text] [Related]
4. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
Chen CC; Wang L; Lin JC; Jan JS
J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
[TBL] [Abstract][Full Text] [Related]
5. Characteristics and Treatments of Patients Aged 65 Years or Over with Cervical Cancer.
Xie S; Pan S; Zou S; Zhu H; Zhu X
Clin Interv Aging; 2020; 15():841-851. PubMed ID: 32606624
[TBL] [Abstract][Full Text] [Related]
6. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
[TBL] [Abstract][Full Text] [Related]
7. The effects of age on treatment and outcomes in women with stages IB1-IIB cervical cancer.
Roque DR; Cronin B; Robison K; Lopes V; Rizack T; Dizon DS
J Geriatr Oncol; 2013 Oct; 4(4):374-81. PubMed ID: 24472482
[TBL] [Abstract][Full Text] [Related]
8. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant therapy after radical surgery for stage IB-IIB cervical adenocarcinoma with risk factors.
Seki T; Tanabe H; Nagata C; Suzuki J; Suzuki K; Takano H; Isonishi S; Ochiai K; Takakura S; Okamoto A
Jpn J Clin Oncol; 2017 Jan; 47(1):32-38. PubMed ID: 27677664
[TBL] [Abstract][Full Text] [Related]
10. Cervical Cancer in Women Aged 35 Years and Younger.
Pelkofski E; Stine J; Wages NA; Gehrig PA; Kim KH; Cantrell LA
Clin Ther; 2016 Mar; 38(3):459-66. PubMed ID: 26899314
[TBL] [Abstract][Full Text] [Related]
11. Cervical carcinoma in the elderly: an analysis of patterns of care and outcome.
Wright JD; Gibb RK; Geevarghese S; Powell MA; Herzog TJ; Mutch DG; Grigsby PW; Gao F; Trinkaus KM; Rader JS
Cancer; 2005 Jan; 103(1):85-91. PubMed ID: 15540239
[TBL] [Abstract][Full Text] [Related]
12. Assessment of treatment factors and clinical outcomes in cervical cancer in older women compared to women under 65 years old.
Diver EJ; Hinchcliff EM; Gockley AA; Melamed A; Contrino L; Feldman S; Growdon WB
J Geriatr Oncol; 2018 Sep; 9(5):516-519. PubMed ID: 29503115
[TBL] [Abstract][Full Text] [Related]
13. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
[TBL] [Abstract][Full Text] [Related]
15. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
17. Multimodal treatment including hysterectomy improves survival in patients with locally advanced cervical cancer: A population-based, propensity score-matched analysis.
Wu SG; Zhang WW; Sun JY; Li FY; He ZY; Zhou J
Int J Surg; 2017 Dec; 48():122-127. PubMed ID: 29032160
[TBL] [Abstract][Full Text] [Related]
18. Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases.
Meanwell CA; Kelly KA; Wilson S; Roginski C; Woodman C; Griffiths R; Blackledge G
Br Med J (Clin Res Ed); 1988 Feb; 296(6619):386-91. PubMed ID: 3125911
[TBL] [Abstract][Full Text] [Related]
19. [Prognostic analysis of stage Ⅰb2 andⅡa2 cervical squamous cancer without high risk factors treated with neo-adjuvant chemotherapy and radical hysterectomy].
Li PP; Li B; Wang YT; Liu SH; Zhang YN; Zhang R; Bai P; Li XG; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2018 Apr; 53(4):248-256. PubMed ID: 29747270
[No Abstract] [Full Text] [Related]
20. Effect of treatment delay on survival in patients with cervical cancer: a historical cohort study.
Perri T; Issakov G; Ben-Baruch G; Felder S; Beiner ME; Helpman L; Hogen L; Jakobson-Setton A; Korach J
Int J Gynecol Cancer; 2014 Sep; 24(7):1326-32. PubMed ID: 25054445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
